SCHEMBL31436047

SCHEMBL31436047

CCN(CC)CCNc1nc(OCCCNC(=O)OC(C)(C)C)nc(OCCCNC(=O)OC(C)(C)C)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STK17B O94768 1/20 0.43
STK17A Q9UEE5 1/20 0.43
CA12 O43570 6/20 0.42
CA1 P00915 6/20 0.42
CA2 P00918 6/20 0.42
CA9 Q16790 6/20 0.42
TDP1 Q9NUW8 1/20 0.39
TLR7 Q9NYK1 3/20 0.39
CKS1B P61024 1/20 0.38
SKP1 P63208 1/20 0.38
SKP2 Q13309 1/20 0.38
ADORA2A P29274 2/20 0.38
ADORA1 P30542 2/20 0.38
ADORA2B P29275 1/20 0.38
MEN1 O00255 1/20 0.38
GAA P10253 1/20 0.38
KMT2A Q03164 1/20 0.38
IL6 P05231 2/20 0.37
STING1 Q86WV6 1/20 0.37
BCHE P06276 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31436088 0.94 TDP1 (0.41) STK17BSTK17ACA12CA1CA2
SCHEMBL31436057 0.86 STK17B (0.48) STK17BSTK17ACA12CA1CA2
SCHEMBL31436104 0.85 TDP1 (0.43) STK17BSTK17ACA12CA1CA2
SCHEMBL31436100 0.80 TDP1 (0.47) STK17BSTK17ACA12CA1CA2
SCHEMBL31436111 0.78 DRD2 (0.44) STK17BSTK17ACA12CA1CA2
SCHEMBL31436039 0.77 STK17B (0.57) STK17BSTK17ACA12CA1CA2
SCHEMBL31436053 0.77 TDP1 (0.50) STK17BSTK17ACA12CA1CA2
SCHEMBL28425597 0.75 TDP1 (0.62) CA12CA1CA2CA9TDP1
SCHEMBL17563634 0.74 STK17B (0.47) STK17BSTK17ACA12CA1CA2
SCHEMBL31436103 0.73 STK17B (0.50) STK17BSTK17ACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025088570-A1 IONIZABLE LIPIDS AND IONIZABLE LIPID NANOPARTICLES CRISPR THERAPEUTICS AG (CH) 2025-05-01 WO disclosed